“Cutting-edge MRI techniques are redefining our understanding of brain disorders. Let′s bring this science into the clinic, where it will change people′s lives.”

David Vaughan, Imaging Lead

“Cognitive and emotional difficulties are core elements of epilepsy, yet are under-diagnosed and under-treated. The AEP will change this, greatly expanding the availability of neuropsychology for Australians living with epilepsy.”

Chris Tailby, Neuropsychology Lead

“The AEP will result in fewer seizures, fewer deaths and better lives.”

Patrick Kwan, Neurologist and AEP Outcomes Lead

“The Australian Epilepsy Project is accelerating medical technology, giving access to healthcare and rewriting the books for epilepsy diagnosis.”

Mangor Pedersen, Artificial Intelligence Lead

“Improved diagnosis and prediction are the keys to progressing epilepsy care. The AEP offers the tools to advance these issues.”

Saul Mullen – Ethics Lead

“Epilepsy does not discriminate. It can strike anyone, at any age. It is a privilege to work on a project towards seizure freedom for everyone.”

Karen Oliver – Genetics Lead

“My goal is to make sure that every Australian living with epilepsy has access to the best and cost-effective care.”

Zanfina Ademi Delaney – Health Economics Lead

Do your patients ask these questions?

Why did I have a seizure?

We are not sure.

You may be one of the 25% where there is a structural cause or 5% with an identifiable genetic cause for your seizure.

We are uncertain what caused your seizure. We are unsure if you will have another. You might need further investigations.

MULTIMODAL ADVANCED TESTING AND ARTIFICIAL INTELLIGENCE

There is a small part of your brain that shows a focal defect, this is causing your seizures.

Will this medication work for me?

We are not sure. Let’s try another one and see.

It is likely this drug will work. Also to confirm its suitability, this genetic test can show us whether you will have serious side effects to this medication before we start.

We are uncertain about which medication will be most effective for you.

MULTIMODAL ADVANCED TESTING AND ARTIFICIAL INTELLIGENCE

We can see from your genetic testing that you would be best suited to medication X.

Is surgery an option for me?

It could be but let’s try some more medication. (Average time to surgery is 20 years)

Medication-resistant epilepsy can be treated by surgery to increase seizure freedom. If you have tried two medications and are still having seizures then surgery may be an option.

We are uncertain what caused your seizure. We are unsure if you will have another. You might need further investigations.

MULTIMODAL ADVANCED TESTING AND ARTIFICIAL INTELLIGENCE

Yes! your advanced imaging result show a focus, lets discuss preparing for surgery.

YOU WILL BE ABLE TO ANSWER THESE QUESTIONS WITH GREATER ACCURACY AND CERTAINTY AS A CLINICAL MEMBER OF THE AUSTRALIAN EPILEPSY PROJECT.

YOUR PATIENTS WILL RECEIVE FREE ADVANCED TESTING ANALYSIS SO THAT YOU CAN PUT THEM ON THE MOST EFFECTIVE TREATMENT PATH.

logo

WHY WE'RE HERE

To give every clinician a decision support tool that is built from advanced testing across three modalities, expert interpretation and integration of the results. The AEP report will be used to confidently guide individual treatment decisions for your patients.

HOW WILL I BENEFIT?

You and your patients will receive :

  1. Easy access to cutting edge, multi-modal data
  2. The AEP report, a clinical decision support tool to guide diagnostic and treatment decisions
  3. A faster route to improved individualised treatment choices

Importantly, you will not be required to change your current procedures or work flow. Just refer to the AEP and let us support you and your patient

HOW CAN I REFER MY PATIENTS TO BECOME AEP COMMUNITY MEMBERS?

They need to be in one of these clinical categories and meet the inclusion criteria.

1
FIRST UNPROVOKED SEIZURE (DEFINITE OR PROBABLE) WITH NO DIAGNOSIS OF EPILEPSY
2
NEW DIAGNOSIS OF EPILEPSY (GENERALISED OR FOCAL)
3
PHARMACORESISTANT FOCAL EPILEPSY

INCLUSION CRITERIA

  • Be aged between 18-60 years
  • Have no moderate-to-severe intellectual disability
  • Be able to perform the testing protocol
  • Be available for follow up within two years
  • Be willing to share their de-identified data to facilitate open research

WHAT WILL BE IN THE AEP REPORT?

CONNECT!

If you are interested in becoming a referring clinician, connect with us:

CONTACT US